IL86909A0 - Hybrid plasminogen activator,dna coding therefor,derivatives of said plasminogen activator and pharmaceutical compositions containing said plasminogen activator or said derivatives - Google Patents

Hybrid plasminogen activator,dna coding therefor,derivatives of said plasminogen activator and pharmaceutical compositions containing said plasminogen activator or said derivatives

Info

Publication number
IL86909A0
IL86909A0 IL86909A IL8690988A IL86909A0 IL 86909 A0 IL86909 A0 IL 86909A0 IL 86909 A IL86909 A IL 86909A IL 8690988 A IL8690988 A IL 8690988A IL 86909 A0 IL86909 A0 IL 86909A0
Authority
IL
Israel
Prior art keywords
plasminogen activator
derivatives
pharmaceutical compositions
compositions containing
dna coding
Prior art date
Application number
IL86909A
Other languages
English (en)
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878715392A external-priority patent/GB8715392D0/en
Priority claimed from GB878715391A external-priority patent/GB8715391D0/en
Priority claimed from GB878719279A external-priority patent/GB8719279D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of IL86909A0 publication Critical patent/IL86909A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL86909A 1987-07-01 1988-06-29 Hybrid plasminogen activator,dna coding therefor,derivatives of said plasminogen activator and pharmaceutical compositions containing said plasminogen activator or said derivatives IL86909A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878715392A GB8715392D0 (en) 1987-07-01 1987-07-01 Compounds
GB878715391A GB8715391D0 (en) 1987-07-01 1987-07-01 Compounds
GB878719279A GB8719279D0 (en) 1987-08-14 1987-08-14 Compounds

Publications (1)

Publication Number Publication Date
IL86909A0 true IL86909A0 (en) 1988-11-30

Family

ID=27263478

Family Applications (1)

Application Number Title Priority Date Filing Date
IL86909A IL86909A0 (en) 1987-07-01 1988-06-29 Hybrid plasminogen activator,dna coding therefor,derivatives of said plasminogen activator and pharmaceutical compositions containing said plasminogen activator or said derivatives

Country Status (11)

Country Link
EP (1) EP0297882B1 (xx)
JP (1) JPS6480287A (xx)
AU (1) AU615919B2 (xx)
DE (1) DE3883453T2 (xx)
DK (1) DK359888A (xx)
FI (1) FI883146A (xx)
HU (1) HUT47151A (xx)
IL (1) IL86909A0 (xx)
NO (1) NO882886L (xx)
NZ (1) NZ225215A (xx)
PT (1) PT87869B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826975D0 (en) * 1988-11-18 1988-12-21 Beecham Group Plc Novel compounds
AU6470590A (en) 1989-10-23 1991-04-26 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids
GB9011861D0 (en) * 1990-05-26 1990-07-18 Beecham Group Plc Novel compounds
GB9013345D0 (en) * 1990-06-14 1990-08-08 Beecham Group Plc Novel compounds
GB9019120D0 (en) * 1990-09-01 1990-10-17 Beecham Group Plc Novel compounds
EP1705248A1 (en) * 1997-10-01 2006-09-27 G.D. Searle LLC. Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment
US6984373B2 (en) 2000-12-23 2006-01-10 Dyax Corp. Fibrin binding moieties useful as imaging agents
JPWO2002094954A1 (ja) * 2001-05-21 2004-09-09 日本ペイント株式会社 金属コロイド高濃度溶液の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
DE3361610D1 (en) * 1982-04-07 1986-02-06 Beecham Group Plc Enzyme derivatives, process for preparing them and pharmaceutical compositions containing them
GB8609948D0 (en) * 1986-04-23 1986-05-29 Beecham Group Plc Compounds
GB8334498D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Compounds
GB8400653D0 (en) * 1984-01-11 1984-02-15 Beecham Group Plc Conjugates
US4916071A (en) * 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation

Also Published As

Publication number Publication date
DK359888D0 (da) 1988-06-29
DE3883453T2 (de) 1994-03-17
AU1853388A (en) 1989-01-19
HUT47151A (en) 1989-01-30
NZ225215A (en) 1991-05-28
JPS6480287A (en) 1989-03-27
EP0297882A3 (en) 1989-08-16
PT87869A (pt) 1989-06-30
FI883146A (fi) 1989-01-02
EP0297882B1 (en) 1993-08-25
EP0297882A2 (en) 1989-01-04
NO882886L (no) 1989-01-02
PT87869B (pt) 1995-03-01
DE3883453D1 (de) 1993-09-30
FI883146A0 (fi) 1988-06-30
NO882886D0 (no) 1988-06-29
AU615919B2 (en) 1991-10-17
DK359888A (da) 1989-01-02

Similar Documents

Publication Publication Date Title
NZ216306A (en) Pharmaceutical compositions containing tissue plasminogen activator
NZ216307A (en) Pharmaceutical compositions containing tissue plasminogen activator
EP0315978A3 (en) New use of 11,28-dioxa-4-azatricyclo û22.3.1.0 4,9¨octacos-18-ene derivatives and pharmaceutical compositions containing them
PH24719A (en) Cephem compound, pharmaceutical composition containing said compound and method of use thereof
HUT41418A (en) Process for producing pharmaceutical compositions containing anticoagulator polipeptides and process for producing the active agents
EP0196920A3 (en) Degraded species of tissue-type plasminogen activator, pharmaceutical composition and method of preparation
IL85972A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
PH24749A (en) Piperidine compounds, pharmaceutical composition and method of use thereof
IL84765A0 (en) Pyridazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
IL87949A0 (en) Dideoxycytidine derivatives,their preparation and pharmaceutical compositions containing them
IL81833A0 (en) Renin inhibitors,their preparation and pharmaceutical compositions containing them
PH24326A (en) Substituted 3,4-dihydro-2h-benzopyrans,pharmaceutical compositions containing same and method of use thereof
IL80232A0 (en) N-substituted diphenylpiperidines,their manufacture and pharmaceutical compositions containing them
PH23447A (en) B-actam compounds,pharmaceutical compositions containing the same and method of use thereof
IL87374A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL86909A0 (en) Hybrid plasminogen activator,dna coding therefor,derivatives of said plasminogen activator and pharmaceutical compositions containing said plasminogen activator or said derivatives
PH24093A (en) Macrolide compounds,pharmaceutical composition containing same and method of use thereof
IL85722A0 (en) Propiolophenone derivatives,their manufacture and pharmaceutical compositions containing them
HUT43848A (en) Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents
IL84728A (en) Bicyclic v-triazine-4-one derivatives,their manufacture and pharmaceutical compositions containing them
IL85970A0 (en) Cephalosporin derivatives,their manufacture and pharmaceutical compositions containing them
IL90745A0 (en) Tissue plasminogen activator analogue and nucleic acid coding for it
IL90171A0 (en) Dideoxynucleoside derivatives and pharmaceutical compositions containing them
PT83231A (en) Process for the preparation of gem-dihalo-1,8-diamino-4-aza-octanes and of pharmaceutical compositions containing the same
ZA863956B (en) Pharmaceutical formulations containing tissue plasminogen activator